Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
Xun Jin,1,* Bingwen Zou,2,* Li Luo,1,* Chuanhong Zhong,3 Peilan Zhang,1 Hao Cheng,1 Yanfang Guo,1 Maling Gou1 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, 2Department of Thoracic Oncology, Cancer...
Saved in:
Main Authors: | Jin X, Zou B, Luo L, Zhong C, Zhang P, Cheng H, Guo Y, Gou M |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/a6088d9695b44c23b8fb97ecaa709ec7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TWO SELECTIVE SPECTROPHOTOMETRY METHODS FOR THE DETERMINATION OF THIORIDAZINE HYDROCHLORIDE IN TABLETS AND IN BIOLOGICAL FLUIDS
by: EL-DIDAMONY,A. M, et al.
Published: (2012) -
Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
by: Tahir N, et al.
Published: (2019) -
Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy
by: Fang J, et al.
Published: (2018) -
Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy
by: Xia Y, et al.
Published: (2017) -
Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment
by: Wang D, et al.
Published: (2017)